HYPERBARIC OXYGEN THERAPY (HBOT) DEVICES MARKET ANALYSIS

Hyperbaric Oxygen Therapy (HBOT) Devices Market Size and Forecast – 2024 to 2031

The Global Hyperbaric Oxygen Therapy (HBOT) Devices Market is estimated to be valued at USD 3.61 Bn in 2024 and is expected to reach USD 5.10 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 5.1% from 2024 to 2031.

Key Takeaways of the Hyperbaric Oxygen Therapy (HBOT) Devices Market:

• By product, the monoplace HBOT devices segment is estimated to contribute the highest share of the market with 43.1% in 2024.
• By application, the wound healing segment is expected to contribute the highest share of the market with 37.1% in 2024.
• By end user, the hospitals segment is expected to contribute the highest share of the market with 41.2% in 2024.
• North America is expected to top the global market with 35.3% share, followed by Asia Pacific with 27.7% share in 2024.

Market Overview:

The growing adoption of Hyperbaric Oxygen Therapy (HBOT) devices for various disease indications such as soft tissue injuries, air or gas embolism, and healing chronic wounds is expected to drive the market growth during the forecast period. The global Hyperbaric Oxygen Therapy (HBOT) devices market is expected to witness a steady growth owing to the rising prevalence of chronic wounds, increasing incidence of conditions such as diabetic wounds and infections where HBOT proves to be an effective therapeutic solution. Furthermore, rising awareness about the therapeutic benefits of HBOT and growth in healthcare expenditure are also contributing to the growth of global hyperbaric oxygen therapy (HBOT) devices market.

Segmental Insights

To learn more about this report, Request sample copy

Product Insights - Monoplace HBOT Devices Dominate due to Enhanced Convenience Offered

In terms of product, the Monoplace HBOT devices segment is estimated to contribute the highest share of the market with 43.1% in 2024 owing to their convenience and portability. Monoplace devices only accommodate one patient at a time but offer high flexibility as they can be easily transported and installed wherever needed. This has boosted their popularity for use in homecare settings, rural clinics, and ambulances where space and infrastructure are major constraints. Their compact size allows for point-of-care treatment with minimal setup requirements. Additionally, the self-contained design of monoplace chambers simplifies logistics and increases affordability compared to complex multiplace units. This has accelerated their adoption across emerging markets with limited healthcare budgets. Monoplace chambers are also favored for their individualized approach that offers complete isolation and hyperbaric conditions tailored to a single patient's therapy needs.

Application Insights - Wound Healing Dominates owing to HBOT’s Application in Wound Management

In terms of application, the wound healing segment is expected to contribute the highest share of the market with 37.1% in 2024 owing to the growing prevalence of non-healing wounds and increased recognition of HBOT as an effective treatment option. Hyperbaric oxygen therapy (HBOT) devices work by stimulating angiogenesis or formation of new blood vessels to improve blood supply and oxygen delivery at the wound site, which is essential for natural wound healing. It is particularly effective for chronic wounds such as diabetic foot ulcers, pressure sores, and wounds resulting from radiation therapy or transplants. With more people suffering from diabetes, vascular diseases and mobility issues, the incidences of hard-to-heal wounds have risen tremendously creating high demand for hyperbaric oxygen therapy. Additionally, recent clinical research has demonstrated HBOT's benefits in accelerating healing of wounds including burns and injuries, further promoting its usage for various traumatic and post-surgical indications.

End User Insights – Hospitals Offer Concentrated Service Delivery

In terms of end user, the hospitals segment is expected to contribute the highest share of the market with 41.2% in 2024 as they serve as the primary centers for delivering hyperbaric oxygen therapy. Hospitals have necessary infrastructure for safely operating complex hyperbaric equipment along with round-the-clock availability of trained medical professionals for monitoring patients undergoing pressurized oxygen treatment. This makes them suitable for management of severe and complicated cases typically seen in hospital set ups. Additionally, co-location of HBOT facilities within hospitals provides convenience to in-patients and ensures streamlined administration for multi-therapeutic procedures. The concentration of specialized staff and resources in hospitals also favors centralized service delivery and economies of scale. This has led to higher procurement of HBOT devices by hospitals compared to other end users to effectively meet increasing in-patient and out-patient therapy needs.

Regional Insights

To learn more about this report, Request sample copy

North America Hyperbaric Oxygen Therapy (HBOT) Devices Market Trends

North America’s dominance in the hyperbaric oxygen therapy (HBOT) devices market with a share of 35.3% in 2024 can be attributed to factors such as the strong presence of leading manufacturers, favorable reimbursement policies, rising incidence of chronic wounds, and cardiovascular diseases. Additionally, the growing healthcare expenditure and awareness among physicians and patients have significantly boosted adoption. Key players like Hyperbaric SAC and Sechrist Industries continue to introduce innovative products and expand access to therapy across the region.

Asia Pacific Hyperbaric Oxygen Therapy (HBOT) Devices Market Trends

Asia Pacific exhibits the fastest growth with a share of 27.7% in 2024, led by countries such as China, India, and Japan. This can be explained by the rising geriatric population, improving access to healthcare facilities, increasing healthcare expenditures, and supportive government initiatives to promote indigenous manufacturing. Notable domestic brands such as Yangzhou Jiahe Hyperbaric Oxygen Therapy Chamber Equipment Co. Ltd. are well-positioned to tap opportunities in the high potential yet untapped markets.

Hyperbaric Oxygen Therapy (HBOT) Devices Market Outlook for Key Countries

U.S. Hyperbaric Oxygen Therapy (HBOT) Devices Market Trends

The U.S. led the hyperbaric oxygen therapy (HBOT) devices market, driving by the demand for wound healing treatments, including hyperbaric oxygen therapy (HBOT). Increased disposable income has encouraged consumers to seek advanced medical therapies. In February 2023, Maui Memorial Medical Center in the U.S. launched a wound care clinic offering comprehensive treatment with HBOT for non-healing wounds.

India Hyperbaric Oxygen Therapy (HBOT) Devices Market Trends

India hyperbaric oxygen therapy (HBOT) devices market witnesses significant growth due to factors like a large population with increasing healthcare needs, a thriving medical tourism industry, and growing awareness of HBOT’s benefits. Government support, affordable healthcare options, and advancements in medical technologies also contribute. Notably, in August 2022, HBOT-India introduced one of the first medical-grade HBOT units in Gurugram, further boosting the market.

Germany Hyperbaric Oxygen Therapy (HBOT) Devices Market Trends

Germany hyperbaric oxygen therapy (HBOT) devices market is supported by government initiatives promoting advanced medical treatments. In January 2023, the German Federal Ministry of Health announced funding for innovative healthcare technologies, which is expected to boost the adoption of HBOT devices in clinical settings.

U.K. Hyperbaric Oxygen Therapy (HBOT) Devices Market Trends

The U.K. hyperbaric oxygen therapy (HBOT) devices market is characterized by a growing emphasis on non-invasive treatment options. In February 2023, the National Health Service (NHS) launched a new initiative to integrate HBOT into standard care practices for chronic wounds, promoting wider use of these devices.

Market Players, Key Devlopment, and Competitive Intelligence

Get actionable strategies to beat competition: Request sample copy

Key Developments:

• In January 2024, Sechrist Industries, a U.S.-based company, introduced the eHEAL software system and the 3300HM Hyperbaric Chamber to advance hyperbaric medicine. The eHEAL system offers automated treatment logging, real-time parameter display, and report generation while supporting multi-chamber connectivity via Ethernet.
• In February 2023, Western University of Health Sciences (WesternU) partnered with NexGen Hyperbaric, a Physiotherapy Center to advance research on hyperbaric oxygen therapy for addressing physical and mental health conditions. The collaboration emphasizes cellular studies and clinical trials focused on traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD).
• In January 2023, ADK Hospital, aprivate tertiary care hospital in Maldives, became the first medical facility in the Maldives to launch a Hyperbaric Treatment Unit, also known as a decompression chamber

Top Strategies Followed by Global Hyperbaric Oxygen Therapy (HBOT) Devices Market Players

• Established Players: Leading companies like Sechrist Industries focus on extensive research and development to innovate high-performance hyperbaric oxygen therapy (HBOT) devices. In June 2023, Sechrist announced an investment of over US$ 5 million in R&D to enhance its HBOT technology, aiming for improved safety and efficacy.
• Focusing on delivering quality, budget-friendly products targets price-sensitive consumers. Companies like OxyHealth offer portable HBOT devices, catering to a broader market segment. Partnerships aimed at enhancing technology and production capabilities are common. Collaborations between startups and established companies have led to the development of advanced HBOT devices.
• Small players often target niche markets. Targeting niche markets with unique features or innovative products allows small players to differentiate themselves. Startups focusing on portable and home-use HBOT devices cater to specific consumer needs.

Emerging Startups - Hyperbaric Oxygen Therapy (HBOT) Devices Industry Ecosystem

• Innovative startups are developing advanced technologies. Hipore Healthcare is creating smart sensors to continuously monitor treatment parameters. BARAmedics uses AI to analyze physiological responses and optimize therapy protocols. This has the potential to personalize care delivery.
• Some startups focus on sustainability. OxyGreen manufactures chambers using recyclable polyethylene and bio-based resins, reducing carbon footprint. Rechambers collects used chambers for refurbishment and parts harvesting in partnership with Emergency Care Research Institute (ECRI).
• Startups also address unique market needs. Oxynova is commercializing a portable pediabarbic device for diabetes wound care in home settings. Subasea partnered with medical institutions to provide aquatic rehabilitation for Parkinson's using HBOT. Partnerships with other companies or institutions drive technological and sustainable innovation. Collaborations in the HBOT sector have led to the development of more accessible treatment options.

Market Report Scope

Market Dynamics

Discover market dynamics shaping the industry: Request sample copy

Hyperbaric Oxygen Therapy (HBOT) Devices Market Growth Driver - Increasing prevalence of chronic diseases such as diabetes and non-healing wounds

Chronic diseases have emerged as one of the major public health challenges in both developed and developing countries. The number of people suffering from diabetes, in particular, has increased exponentially over the past few decades.. Diabetes severely impacts wound healing and several patients struggle with non-healing wounds for prolonged periods. Hyperbaric oxygen therapy has proven to be an effective treatment option for diabetic wounds and other non-healing chronic wounds that are not responding to conventional treatments. For instance, In October 2021, according to the National Library of Medicine, nearly 500 million people are currently affected by diabetes mellitus (DM), with an anticipated significant increase in the coming years. In the U.S., over US$ 300 billion is spent annually on medical costs and lost workdays due to DM. It is estimated that one in three to one in five DM patients will develop a chronic non-healing wound, such as a diabetic foot ulcer (DFU), with a high recurrence rate (40% within one year and 65% within five years).

Hyperbaric Oxygen Therapy (HBOT) Devices Market Challenge - Stringent regulatory requirements for device approval and market entry

One of the major challenges faced by manufacturers in the global hyperbaric oxygen therapy (HBOT) devices market is stringent regulatory requirements for device approval and market entry. Obtaining regulatory clearance is a lengthy, expensive, and complex process. Regulatory bodies such as the U.S. Food and Drug Administration (FDA) and European CE (Conformite Europeenne) impose rigorous standards and guidelines regarding the safety, efficacy and performance of HBOT devices. Manufacturers need to generate extensive technical, pre-clinical, and clinical data to prove that their devices are reasonably safe and effective for the intended use. Any change or modification to an approved device may require additional regulatory review and clearance. Moreover, regulations vary across countries which makes the approval process even more complicated for companies seeking to market their devices on a global scale.

Hyperbaric Oxygen Therapy (HBOT) Devices Market Opportunities - Expansion of indications for HBOT in treating various medical conditions

One of the major opportunities in the global hyperbaric oxygen therapy (HBOT) devices market is the expansion of approved indications for treating various medical conditions using HBOT. Historically, HBOT was primarily used for decompression sickness and carbon monoxide poisoning. However, ongoing research has proven its efficacy for a wider range of soft tissue infections, diabetes, multiple sclerosis, and stroke, among others. Key players are actively collaborating with research institutions and hospitals to conduct large clinical trials to gather clinical evidence for expanding usage of HBOT. With growing acceptance of HBOT as an adjunct or alternative therapy, more insurance companies are likely to provide coverage which will increase accessibility.

Analyst Opinion (Expert Opinion)

• The increasing prevalence of non-healing wounds such as diabetic foot ulcers and pressure sores is a major growth driver for hyperbaric oxygen therapy (HBOT) devices market. Rising geriatric population who are prone to such chronic wounds will continue to support market growth. Further, growing awareness about the benefits of HBOT in treating conditions like decompression sickness will boost demand. The market is also expected to witness increased demand from the Asia Pacific region fueled by growing medical tourism as treatment costs are lower compared to developed regions.
• However, the market may face restraints from stringent regulatory approvals and reimbursement policies regarding HBOT coverage. Demonstrating effectiveness over alternative treatment options remains a challenge as well. Lack of clinical evidence for certain applications could slow the market’s growth trajectory. Furthermore, the high capital investment required for HBOT chambers may deter new entrants.
• To overcome such challenges, players could focus on collaborating with key opinion leader. to undertake clinical trials and boost clinical adoption. Also, targeting emerging markets in Asia Pacific with marketing tie-ups will aid business expansion. Developing portable and low-cost HBOT devices can facilitate greater accessibility and penetration into new regions.

Market Segmentation

• By Product Insights (Revenue, USD Bn, 2019 - 2031)
  • Monoplace HBOT Devices
  • Multiplace HBOT Devices
  • Topical HBOT Devices
• By Application Insights (Revenue, USD Bn, 2019 - 2031)
  • Wound Healing
  • Decompression Sickness
  • Infection Treatment
  • Gas Embolism
  • Others
• By End User Insights (Revenue, USD Bn, 2019 - 2031)
  • Hospitals
  • Clinics
  • Ambulatory Surgery Centers
  • Home Care Settings
• Regional Insights (Revenue, USD Bn, 2019 - 2031)
  
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • Fink Engineering
  • ETC Hyperbaric Chambers
  • HAUX-LIFE-SUPPORT
  • Gulf Coast Hyperbarics Inc.
  • HEARMEC
  • Sechrist Industries
  • OxyHealth
  • Perry Baromedical
  • Hyperbaric Medical Solutions
  • Hyperbaric Technologies
  • Airox Technologies
  • Braun Melsungen AG
  • Medtronic
  • Smiths Medical